Your browser doesn't support javascript.
loading
Setting ambitious targets for surveillance and treatment rates among patients with hepatitis C related cirrhosis impacts the cost-effectiveness of hepatocellular cancer surveillance and substantially increases life expectancy: A modeling study.
Uyei, Jennifer; Taddei, Tamar H; Kaplan, David E; Chapko, Michael; Stevens, Elizabeth R; Braithwaite, R Scott.
Afiliação
  • Uyei J; Division of Comparative Effectiveness and Decision Science, Department of Population Health, New York University School of Medicine, New York, NY, United States of America.
  • Taddei TH; VA Connecticut-Healthcare System, West Haven, CT, United States of America.
  • Kaplan DE; Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, United States of America.
  • Chapko M; Center of Innovation for Veteran-Centered and Value-Driven Care, Health Services Research & Development, VA Puget Sound, Seattle, WA, United States of America.
  • Stevens ER; Division of Comparative Effectiveness and Decision Science, Department of Population Health, New York University School of Medicine, New York, NY, United States of America.
  • Braithwaite RS; Division of Comparative Effectiveness and Decision Science, Department of Population Health, New York University School of Medicine, New York, NY, United States of America.
PLoS One ; 14(8): e0221614, 2019.
Article em En | MEDLINE | ID: mdl-31449554
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Expectativa de Vida / Análise Custo-Benefício / Hepatite C / Cirrose Hepática / Neoplasias Hepáticas / Modelos Biológicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Expectativa de Vida / Análise Custo-Benefício / Hepatite C / Cirrose Hepática / Neoplasias Hepáticas / Modelos Biológicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article